Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine for Schizophrenia
NCT00140192Phase 3Completed
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Sep 2004
- Primary completion
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of creatine in schizophrenia, sponsored by Be'er Sheva Mental Health Center. Started Sep 2004; status: completed.
02
Drugs
creatine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00140192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140192.